New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
ETF Central logo
Advertisement

BBPvsXPHETF Comparison

ETF 1
BBP

Virtus LifeSci Biotech Products ETF

This fund is part of
Tomorrow's Treatments
-0.51%
Full BBP fund page
VS
ETF 2
XPH

SPDR S&P Pharmaceuticals ETF

This fund is part of
US Health Care
-0.3%
Full XPH fund page

Virtus LifeSci Biotech Products ETF (BBP) belongs to the Tomorrow's Treatments segment. SPDR S&P Pharmaceuticals ETF (XPH) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Health Care. BBP is more expensive with a Total Expense Ratio (TER) of 0.79%, versus 0.35% for XPH. BBP is up 5.62% year-to-date (YTD) with +$4M in YTD flows. XPH performs worse with -5.13% YTD performance, and +$96M in YTD flows. Run a side-by-side ETF comparison of BBP and XPH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

BBP vs XPH performance and flow charts

Performance

-6.0-4.0-2.00.02.04.06.0%Feb 11Feb 19Feb 26Mar 5Mar 12

Cumulative Flows

0 M5 M10 M15 M20 MFeb 11Feb 19Feb 26Mar 5Mar 12

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 03/11/2026
1M3MYTD1Y3Y5Y
Perf.
BBP
XPH
+2.73%-6.46%
+7.35%-4.96%
+5.62%-5.13%
+41.19%+26.10%
+72.79%+37.18%
+54.18%+4.53%
Flows
BBP
XPH
+$4M+$20M
+$16M+$103M
+$4M+$96M
+$19M+$121M
+$19M+$56M
+$9M+$44M
Volatility and drawdown
3M1Y3Y5Y
Volatility
BBP
XPH
+24.64%+21.49%
+25.49%+23.31%
+23.37%+19.10%
+26.10%+20.31%
Max drawdown
BBP
XPH
-7.42%-8.79%
-17.97%-17.10%
-25.54%-23.45%
-38.24%-32.89%
Max drawdown duration
BBP
XPH
32d16d
106d140d
292d322d
915d1703d
Trading data

Create an account to view trading data

Join for free
BBP
XPH
Last sale
3/13/2026 at 1:30 PM
$81.25
$53.25
Previous close
03/12/2026
$81.68
$53.64
Consolidated volume
03/12/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of February 27, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
BBP
XPH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 3/13/2026 at 1:30 PM
Live
Closed
BBP
XPH
Last price
$81.25
$53.25
1D performance
-0.53%
-0.73%
AuM$50.55 M$308.63 M
E/R0.79%0.35%
Characteristics
BBP
XPH
Management strategyPassivePassive
ProviderVIRTUS Investment PartnersSPDR
BenchmarkLifeSci Biotechnology Products IndexS&P Pharmaceuticals Select Industry Index
N° of holdings5849
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateDecember 16, 2014June 19, 2006
ESGNoNo
Advertisement
Exposure

Countries

BBP
USA
90.82%
Other
9.18%
XPH
USA
85.59%
Other
14.41%

Sectors

BBP
Health Care
88.88%
Other
11.12%
XPH
Health Care
81.97%
Other
18.03%
Advertisement

Diversification

BBP

Total weight of top 15 holdings out of 15

30.11%
XPH

Total weight of top 15 holdings out of 15

32.4%

Top 15 holdings

Data as of January 31, 2026
BBP
DAY ONE BIOPHARMACEUTICALS
2.39%
DYNAVAX TECHNOLOGIES
2.39%
AMICUS THERAPEUTICS
2.25%
IOVANCE BIOTHERAPEUTICS INC
2.18%
ARDELYX
2.09%
AXSOME THERA CMN STK
2.07%
BIONTECH SE ADR
2.07%
GILEAD SCIENCES
1.90%
KRYSTAL BIOTECH INC
1.89%
HALOZYME THERAPEUTICS
1.86%
US52635N1037
1.85%
AMGEN-T
1.83%
THERAVANCE BIOPHARMA
1.80%
INCYTE
1.78%
EXELIXIS
1.77%
XPH
LIQUIDIA CORPORATION
2.45%
US55287L1017
2.41%
AXSOME THERA CMN STK
2.33%
ORGANON & CO
2.25%
EDGEWISE THERAPEUTICS
2.24%
ELANCO ANIMAL HEALTH INC
2.13%
MERCK & CO INC
2.13%
VIATRIS INC
2.13%
AMNEAL PHARMACEUTICALS INC
2.12%
JOHNSON&JOHNSON
2.08%
ROYALTY PHARMA
2.06%
AMYLYX PHARMACEUTICALS
2.04%
BRISTOL-MYERS SQUIBB
2.03%
XERIS BIOPHARMA HOLDINGS INC
2.00%
ZOETIS INC
2.00%
Frequently asked questions about BBP and XPH

How have the BBP and XPH ETFs performed in 2026?

As of March 11, 2026, BBP is up 5.62% year-to-date (YTD), while XPH has lost -5.13%. That puts BBP better performer ahead so far this year.

Which ETF is attracting more investor money: BBP or XPH?

Year-to-date, the BBP ETF saw +$4M in flows, compared to +$96M for XPH.

Which ETF is more volatile: BBP or XPH?

Over the past year, BBP had a volatility of 25.49%, while XPH experienced 23.31%.

Which ETF is bigger: BBP or XPH?

As of March 11, 2026, BBP holds $50.55 M in assets under management (AUM), while XPH manages $308.63 M.

What sectors do the BBP and XPH ETFs invest in?

BBP leans toward sectors like Health Care. Meanwhile, XPH focuses on Health Care.

What are the top holdings of the BBP ETF and XPH ETF?

BBP top holdings include DAY ONE BIOPHARMACEUTICALS, DYNAVAX TECHNOLOGIES and AMICUS THERAPEUTICS. XPH holds in its top three: LIQUIDIA CORPORATION, US55287L1017 and AXSOME THERA CMN STK.

Which ETF is more diversified: BBP or XPH?

BBP holds 63 securities with 30.11% of its assets in the top 15. XPH has 57 securities and a top 15 weight of 32.4%.

Advertisement
Advertisement
Advertisement
ETF Comparison Tool

Have you tried our ETF Compare tool?

Compare ETFs like a pro. Analyze fees, performance, exposure & holdings side-by-side.